UB Paderborn / Katalog / Suche / in CDI

1 – 19 von 19

Sortiert nach

The rate of RET mutation testing in medullary thyroid cancer in the Republic of Ireland

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.e12516-e12516

2015

Link zum Volltext

Verfügbarkeit prüfen

Metronomic dosing of selinexor in select soft tissue sarcomas (STS)

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.11557-11557

2023

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of immune checkpoint inhibitors (ICI) treatment in special populations of metastatic renal cell carcinoma (mRCC)

Journal of clinical oncology, 2020-02, Vol.38 (6_suppl), p.673-673

2020

Link zum Volltext

Verfügbarkeit prüfen

Circulating tumor DNA (ctDNA) detection of molecular residual disease (MRD) as a potential biomarker in localized soft tissue sarcoma (STS)

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.11547-11547

2022

Link zum Volltext

Verfügbarkeit prüfen

Phase 1b study of weekly split-dose selinexor in soft tissue sarcoma (STS)

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.11563-11563

2022

Link zum Volltext

Verfügbarkeit prüfen

Is there a role for surgery after chemotherapy in recurrent/metastatic adrenal cortical cancer (ACC)?

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.5092-5092

2022

Link zum Volltext

Verfügbarkeit prüfen

Immune signature and molecular profiling of radiation-induced sarcoma (RIS)

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.11040-11040

2019

Link zum Volltext

Verfügbarkeit prüfen

Molecular residual disease (MRD) detection using bespoke circulating tumor DNA (ctDNA) assays in localized soft tissue sarcoma (STS)

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.11509-11509

2023

Link zum Volltext

Verfügbarkeit prüfen

Persistence of platinum in semen of cisplatin-treated survivors of advanced testicular cancer

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.5056-5056

2020

Link zum Volltext

Verfügbarkeit prüfen

Recurrent or metastatic salivary gland tumor (MSGT) patients treated with selinexor, a first in class selective exportin-1 (XPO1) inhibitor

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.6586-6586

2020

Link zum Volltext

Verfügbarkeit prüfen

Phase 1b study of selinexor, a first-in-class selective inhibitor of nuclear export (SINE) compound, in combination with doxorubicin in patients (pts) with locally advanced or metastatic soft tissue sarcoma (STS)

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.3123-3123

2019

Link zum Volltext

Verfügbarkeit prüfen

Persistence of platinum in semen of cisplatin-treated survivors of advanced testicular cancer

Journal of clinical oncology, 2019-03, Vol.37 (7_suppl), p.519-519

2019

Link zum Volltext

Verfügbarkeit prüfen

Molecular profiling and targeted agents in recurrent, metastatic salivary gland tumor (R/M SGT) patients (pts) treated at two academic centers

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.6081-6081

2021

Link zum Volltext

Verfügbarkeit prüfen

Phase 1b study of selinexor, a first in class selective inhibitor of nuclear export (SINE) compound, in combination with doxorubicin in patients (pts) with locally advanced or metastatic soft tissue sarcoma (STS)

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.11562-11562

2018

Link zum Volltext

Verfügbarkeit prüfen

De novo metastatic prostate cancer: Patterns of PSA testing prediagnosis and disease characteristics

Journal of clinical oncology, 2017-02, Vol.35 (6_suppl), p.271-271

2017

Link zum Volltext

Verfügbarkeit prüfen

An evaluation of administrative data linkage for measurement of real-world outcomes of large clinical panel sequencing for advanced solid tumors

Journal of clinical oncology, 2020-10, Vol.38 (29_suppl), p.283-283

2020

Link zum Volltext

Verfügbarkeit prüfen

Clinical characteristics of nonosteogenic, non-Ewing’s sarcoma of the bone: Experience at the Toronto Sarcoma Program

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.11029-11029

2019

Link zum Volltext

Verfügbarkeit prüfen

An evaluation of administrative data linkage for measurement of real-world outcomes of large clinical panel sequencing for advanced solid tumors

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.e19303-e19303

2020

Link zum Volltext

Verfügbarkeit prüfen

Canadian profiling and targeted agent utilization trial (CAPTUR/PM.1): A phase II basket precision medicine trial

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.TPS12127-TPS12127

2018

Link zum Volltext

Verfügbarkeit prüfen

1 – 19 von 19

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(19)
Mit Volltextzugriff
(19)

Publikationsform

Artikel
(19)

Sprache

Englisch
(19)

Erscheinungsjahr

n.n

Kollektion

EZB Electronic Journals Library
(19)
Ovid SocietyJournals and Single Titles
(19)
Publisher website
(19)
IngentaConnect Journals
(6)
Ingenta
(6)

Zeitschrift / Serie

Journal Of Clinical Oncology
(19)

Menü

Weitere Dienste

Einstellungen

The rate of RET mutation testing in medullary thyroid cancer in the Republic of Ireland

Metronomic dosing of selinexor in select soft tissue sarcomas (STS)

Efficacy of immune checkpoint inhibitors (ICI) treatment in special populations of metastatic renal cell carcinoma (mRCC)

Circulating tumor DNA (ctDNA) detection of molecular residual disease (MRD) as a potential biomarker in localized soft tissue sarcoma (STS)

Phase 1b study of weekly split-dose selinexor in soft tissue sarcoma (STS)

Is there a role for surgery after chemotherapy in recurrent/metastatic adrenal cortical cancer (ACC)?

Immune signature and molecular profiling of radiation-induced sarcoma (RIS)

Molecular residual disease (MRD) detection using bespoke circulating tumor DNA (ctDNA) assays in localized soft tissue sarcoma (STS)

Persistence of platinum in semen of cisplatin-treated survivors of advanced testicular cancer

Recurrent or metastatic salivary gland tumor (MSGT) patients treated with selinexor, a first in class selective exportin-1 (XPO1) inhibitor

Phase 1b study of selinexor, a first-in-class selective inhibitor of nuclear export (SINE) compound, in combination with doxorubicin in patients (pts) with locally advanced or metastatic soft tissue sarcoma (STS)

Persistence of platinum in semen of cisplatin-treated survivors of advanced testicular cancer

Molecular profiling and targeted agents in recurrent, metastatic salivary gland tumor (R/M SGT) patients (pts) treated at two academic centers

Phase 1b study of selinexor, a first in class selective inhibitor of nuclear export (SINE) compound, in combination with doxorubicin in patients (pts) with locally advanced or metastatic soft tissue sarcoma (STS)

De novo metastatic prostate cancer: Patterns of PSA testing prediagnosis and disease characteristics

An evaluation of administrative data linkage for measurement of real-world outcomes of large clinical panel sequencing for advanced solid tumors

Clinical characteristics of nonosteogenic, non-Ewing’s sarcoma of the bone: Experience at the Toronto Sarcoma Program

An evaluation of administrative data linkage for measurement of real-world outcomes of large clinical panel sequencing for advanced solid tumors

Canadian profiling and targeted agent utilization trial (CAPTUR/PM.1): A phase II basket precision medicine trial

Suchergebnisse filtern